Iran has excelled at diagnosing and treating multiple sclerosis (MS) in the Middle East, said secretary of the 13th International Multiple Sclerosis (MS) Congress, which was held in the capital Tehran on November 9-11.
Multiple sclerosis (MS) may be triggered by the death of brain cells that make the insulation around nerve fibers, a surprising new view of the disease reported in a study from Northwestern Medicine and The University of Chicago. And a specially developed nanoparticle prevented MS even after the death of those brain cells, an experiment in the study showed, phys.org reported.
Genetic findings support observational evidence that lower vitamin D levels are associated with increased risk of multiple sclerosis (MS), according to a new research by Brent Richards, from McGill University.
New findings reveal that decreased connectivity between network-specific brain regions are to blame for the central deficit common to the various cognitive changes associated with multiple sclerosis (MS), slowed cognitive speed.
A pair of topical medicines (miconazole and clobetasol) already alleviating skin conditions each may prove to have another, even more compelling use: instructing stem cells in the brain to reverse damage caused by multiple sclerosis (MS).